2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Endocrine
1
Conditions
Breast Neoplasms
10
Colorectal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
7
Pancreatic Neoplasms
5
Neoplastic Cells, Circulating
4
Neoplasm Metastasis
4
Biliary Tract Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Recurrence
3
Prostatic Neoplasms
3
Oropharyngeal Neoplasms
3
Neoplasm, Residual
3
Disease
3
Nevi and Melanomas
2
Neuroendocrine Tumors
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
NSCLC
2
Melanoma
2
Head and Neck Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Hepatocellular
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Smoking
1
Interventions
veliparib
1
vandetanib
1
pralsetinib
1
osimertinib
1
cemiplimab
1
alectinib
1
Vascular Endothelial Growth Factor A
1
Temozolomide
1
Sorafenib
1
Paclitaxel
1
Liquid Biopsy
1
GSK3352589
1
Docetaxel
1
Crizotinib
1
Carboplatin
1
Capecitabine
1
Antibodies, Bispecific
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Multiple Endocrine Neoplasia Type 2a
×
Liquid Biopsy
×
Clear all
NCT06081270
2023-10-13
MUT-ONC
University of Milano Bicocca
Unknown
20 enrolled